10.1186/s12987-020-00196-2 240 SongQ.DengY.YangX.BaiY.XuB.LiuW.et al (2016)
The science of weight loss drugs and SIBO However, a big recent study linked increased hydrogen SIBO diagnosis among obese patients using weight loss medications
Seiwerth and colleagues (Inflammopharmacology, 1999) documented effects on angiogenic growth factor pathway signalling, and subsequent work has expanded characterisation to include VEGF receptor 2 upregulation, endothelial cell migration in capillary-formation assays, and improved healing in ischemia-reperfusion preparations
The company said it was planning to release additional data from the REDEFINE 2 trial, focusing on patients with type-2 diabetes, in 2025
A more systemic approach is whats needed and it starts with holding digital platforms accountable to take real responsibility for fuelling such profiles in the first place, she said
Rare cases of pancreatitis and gallbladder disease have been reported, requiring medical monitoring